Literature DB >> 1967540

A de novo and heterozygous gene deletion causing a variant of von Willebrand disease.

F Bernardi1, G Marchetti, S Guerra, A Casonato, D Gemmati, P Patracchini, G Ballerini, F Conconi.   

Abstract

An abnormal von Willebrand factor (vWF) gene restriction pattern has been found in a patient with von Willebrand disease. Because this gene alteration is not present in his parents or in 50 normal and 25 affected subjects, and the restriction fragment length polymorphism haplotypes are inherited normally in the patient's family, we suggest that a de novo mutation is present. Bands with reduced intensity and additional fragments, observed in several restriction digests, hybridize with noncontiguous copy DNA (cDNA) portions, thus indicating the presence of a heterozygous gene deletion. The deletion removes a genomic region containing at least codons 1147 through 1854 and corresponding to the D3-A3 homologous protein domains. The extent of the vWF pseudogene on chromosome 22 is roughly similar to that of the deleted area. However, the pseudogenic nature of the deletion is excluded by the mapping of bands with reduced intensity in the patient to the true vWF gene. The vWF antigen levels are one fourth of normal and ristocetin cofactor activity is severely impaired. The reduction of high molecular weight multimers in plasma and platelets and the altered triplet morphology are compatible with the presence of a dominant variant of type II von Willebrand disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967540

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.

Authors:  Daniel J Hampshire; Anne C Goodeve
Journal:  Haematologica       Date:  2011-06       Impact factor: 9.941

2.  Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region.

Authors:  F Bernardi; P Patracchini; D Gemmati; M Ferrati; P Arcieri; M Papacchini; R Redaelli; F Baudo; G Mariani; G Marchetti
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

3.  Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).

Authors:  G Marchetti; P Patracchini; D Gemmati; V DeRosa; M Pinotti; G Rodorigo; A Casonato; A Girolami; F Bernardi
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

4.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

5.  Genetic heterogeneity of severe von Willebrand disease type III in the German population.

Authors:  R Schneppenheim; S Krey; F Bergmann; D Bock; U Budde; M Lange; R Linde; U Mittler; E Meili; G Mertes
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

6.  Molecular study of human growth hormone gene cluster in three families with isolated growth hormone deficiency and similar phenotype.

Authors:  E Cacciari; P Pirazzoli; S Gualandi; C Baroncini; L Baldazzi; B Trevisani; M Capelli; S Zucchini; A Balsamo; A Cicognani
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.